The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Guidelines for performing Mendelian randomization investigations
Open accessAbstract
This paper provides guidelines for performing Mendelian randomization investigations. It is aimed at practitioners seeking to undertake analyses and write up their findings, and at journal editors and reviewers seeking to assess Mendelian randomization manuscripts. The guidelines are divided into nine sections: motivation and scope, data sources, choice of genetic variants, variant harmonization, primary analysis, supplementary and sensitivity analyses (one section on robust methods and one on other approaches), data presentation, and interpretation. These guidelines will be updated based on feedback from the community and advances in the field. Updates will be made periodically as needed, and at least every 18 months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Inoshita, M., Numata, S., Tajima, A., Kinoshita, M., Umehara, H., Nakataki, M., Ikeda, M., Maruyama, S., Yamamori, H., Kanazawa, T., et al. (2018) · Scientific Reports · doi:10.1038/srep46947 · Cited by 10
RetractedBowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Self-citationBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
Self-citationVerbanck, M., Chen, C.-Y., Neale, B., & Do, R. (2018) · Nature Genetics · doi:10.1038/s41588-018-0099-7 · Cited by 8,591
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies
Schizophrenia Working Group of the Psychiatric Genomics Consortium, Bulik-Sullivan, B. K., Loh, P.-R., Finucane, H. K., Ripke, S., Yang, J., Patterson, N., Daly, M. J., Price, A. L., & Neale, B. M. (2015) · Nature Genetics · doi:10.1038/ng.3211 · Cited by 5,559
Interpreting findings from Mendelian randomization using the MR-Egger method.
Burgess, S., & Thompson, S. G. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0255-x · Cited by 4,571
Self-citationReading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Davies, N. M., Holmes, M. V., & Davey Smith, G. (2018) · BMJ · doi:10.1136/bmj.k601 · Cited by 4,404
Self-citationGiambartolomei, C., Vukcevic, D., Schadt, E. E., Franke, L., Hingorani, A. D., Wallace, C., & Plagnol, V. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004383 · Cited by 4,261
Avoiding bias from weak instruments in Mendelian randomization studies
Burgess, S., Thompson, S. G., & CRP CHD Genetics Collaboration (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr036 · Cited by 3,952
Self-citation
Research works printed but not linked: 59
- 2019, STROBE-MR: Guidelines for strengthening the reporting of Mendelian randomization studies., PeerJ., 10.7287/peerj.preprints.27857 · DOI
- V Didelez, 2007, Mendelian randomization as an instrumental variable approach to causal inference., Stat Methods Med Res., 16, 309-330, 10.1177/0962280206077743 · DOI · Paper page
- T VanderWeele, 2014, Methodological challenges in Mendelian randomization., Epidemiology., 25, 427-435, 10.1097/EDE.0000000000000081 · DOI · Paper page
- L Millard, 2015, MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization., Sci Rep., 5, 10.1038/srep16645 · DOI
- X Li, 2018, MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank., Ann Rheum Dis., 77, 1039-1047, 10.1136/annrheumdis-2017-212534 · DOI
- G Hemani, 2018, The MR-Base platform supports systematic causal inference across the human phenome., eLife., 7, 10.7554/eLife.34408 · DOI · Paper page
- S Burgess, 2013, Mendelian randomization analysis with multiple genetic variants using summarized data., Genet Epidemiol., 37, 658-665, 10.1002/gepi.21758 · DOI · Paper page
- J Rees, 2019, Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates., PLoS One., 14, e0222362, 10.1371/journal.pone.0222362 · DOI · Paper page
- Q Zhao, 2018, Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score., arXiv.
- S Burgess, 2019, A robust and efficient method for Mendelian randomization with hundreds of genetic variants: unravelling mechanisms linking HDL-cholesterol and coronary heart disease., bioRxiv., 10.1101/566851 · DOI
- E Slob, 2019, A comparison of robust Mendelian randomization methods using summary data., bioRxiv., 10.1101/577940 · doi:10.1101/577940
- S Burgess, 2016, Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods., Stat Med., 35, 1880-1906, 10.1002/sim.6835 · DOI · Paper page
- S Swanson, 2018, Causal null hypotheses of sustained treatment strategies: What can be tested with an instrumental variable?, Eur J Epidemiol., 33, 723-728, 10.1007/s10654-018-0396-6 · DOI
- J Bowden, 2017, A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization., Stat Med., 36, 1783-1802, 10.1002/sim.7221 · DOI · Paper page
- S Burgess, 2014, Instrumental variable analysis with a nonlinear exposure-outcome relationship., Epidemiology., 25, 877-885, 10.1097/EDE.0000000000000161 · DOI
- J Staley, 2017, Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization., Genet Epidemiol., 41, 341-352, 10.1002/gepi.22041 · DOI · Paper page
- B Pierce, 2013, Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators., Am J Epidemiol., 178, 1177-1184, 10.1093/aje/kwt084 · DOI · Paper page
- S Burgess, 2016, Bias due to participant overlap in two-sample Mendelian randomization., Genet Epidemiol., 40, 597-608, 10.1002/gepi.21998 · DOI · Paper page
- D Swerdlow, 2016, Selecting instruments for Mendelian randomization in the wake of genome-wide association studies., Int J Epidemiol., 45, 1600-1616, 10.1093/ije/dyw088 · DOI · Paper page
- S Burgess, 2017, Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants., Epidemiology., 28, 30-42, 10.1097/EDE.0000000000000559 · DOI · Paper page
- M Brion, 2013, Calculating statistical power in Mendelian randomization studies., Int J Epidemiol., 42, 1497-1501, 10.1093/ije/dyt179 · DOI · Paper page
- Q Zhao, 2019, Powerful three-sample genome-wide design and robust statistical inference in summary-data Mendelian randomization., Int J Epidemiol., 48, 1478-1492, 10.1093/ije/dyz142 · DOI · Paper page
- G Davey Smith, 2014, Mendelian randomization: genetic anchors for causal inference in epidemiological studies., Hum Mol Genet., 23, R89-R98, 10.1093/hmg/ddu328 · DOI · Paper page
- F Hartwig, 2016, Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique., Int J Epidemiol., 45, 1717-1726, 10.1093/ije/dyx028 · DOI · Paper page
- D Lawlor, 2008, Mendelian randomization: using genes as instruments for making causal inferences in epidemiology., Stat Med., 27, 1133-1163, 10.1002/sim.3034 · DOI · Paper page
- T Palmer, 2011, Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses., Am J Epidemiol., 173, 1392-1403, 10.1093/aje/kwr026 · DOI · Paper page
- A Inoue, 2010, Two-Sample Instrumental Variables Estimators., Rev Econ Stat., 92, 557-561, 10.1162/REST_a_00011 · DOI · Paper page
- J Thompson, 2016, Mendelian Randomization using Public Data from Genetic Consortia., Int J Biostat., 12, 10.1515/ijb-2015-0074 · DOI
- S Walter, 2015, Revisiting Mendelian randomization studies of the effect of body mass index on depression., Am J Med Genet B Neuropsychiatr Genet., 168B, 108-115, 10.1002/ajmg.b.32286 · DOI
- J Bowden, 2017, A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization., Stat Med., 36, 1783-1802, 10.1002/sim.7221 · DOI · Paper page
- S Burgess, 2015, Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects., Am J Epidemiol., 181, 251-260, 10.1093/aje/kwu283 · DOI · Paper page
- E Sanderson, 2019, An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings., Int J Epidemiol., 48, 713-727, 10.1093/ije/dyy262 · DOI · Paper page
- S Burgess, 2014, Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions., PLoS One., 9, e108891, 10.1371/journal.pone.0108891 · DOI
- S Larsson, 2019, Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study., Euro Heart J., 10.1093/eurheartj/ehz388 · DOI · Paper page
- S Burgess, 2017, Dissecting Causal Pathways Using Mendelian Randomization with Summarized Genetic Data: Application to Age at Menarche and Risk of Breast Cancer., Genetics., 207, 481-487, 10.1534/genetics.117.300191 · DOI · Paper page
- J Rees, 2017, Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy., Stat Med., 36, 4705-4718, 10.1002/sim.7492 · DOI · Paper page
- J Bowden, 2016, Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic., Int J Epidemiol., 45, 1961-1974, 10.1093/ije/dyw220 · DOI · Paper page
- J Thompson, 2017, Mendelian randomization incorporating uncertainty about pleiotropy., Stat Med., 36, 4627-4645, 10.1002/sim.7442 · DOI
- S Burgess, 2018, Modal-based estimation via heterogeneity-penalized weighting: model averaging for consistent and efficient estimation in Mendelian randomization when a plurality of candidate instruments are valid., Int J Epidemiol., 47, 1242-1254, 10.1093/ije/dyy080 · DOI
- G Qi, 2019, A Comprehensive Evaluation of Methods for Mendelian Randomization Using Realistic Simulations of Genome-wide Association Studies., bioRxiv., 10.1101/702787 · DOI
- J Bowden, 2019, Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption., Int J Epidemiol., 48, 728-742, 10.1093/ije/dyy258 · DOI · Paper page
- J Bowden, 2018, Invited Commentary: Detecting Individual and Global Horizontal Pleiotropy in Mendelian Randomization-A Job for the Humble Heterogeneity Statistic?, Am J Epidemiol., 187, 2681-2685, 10.1093/aje/kwy185 · DOI · Paper page
- L Corbin, 2016, BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization., Diabetes., 65, 3002-3007, 10.2337/db16-0418 · DOI · Paper page
- J Smith, 2014, Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis., JAMA., 312, 1764-1771, 10.1001/jama.2014.13959 · DOI · Paper page
- Y Cho, 2018, MR-TRYX: Exploiting horizontal pleiotropy to infer novel causal pathways., bioRxiv., 10.1101/476085 · DOI
- C Minelli, 2018, Age at puberty and risk of asthma: A Mendelian randomisation study., PLoS Med., 15, e1002634, 10.1371/journal.pmed.1002634 · DOI
- F Hormozdiari, 2014, Identifying causal variants at loci with multiple signals of association., Genetics., 198, 497-508, 10.1534/genetics.114.167908 · DOI · Paper page
- N Solovieff, 2013, Pleiotropy in complex traits: challenges and strategies., Nat Rev Genet., 14, 483, 10.1038/nrg3461 · DOI · Paper page
- I Millwood, 2019, Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China., Lancet., 393, 1831-1842, 10.1016/S0140-6736(18)31772-0 · DOI · Paper page
- H van Kippersluis, 2018, Pleiotropy-robust Mendelian randomization., Int J Epidemiol., 47, 1279-1288, 10.1093/ije/dyx002 · DOI · Paper page
- W Spiller, 2019, Detecting and correcting for bias in Mendelian randomization analyses using Gene-by-Environment interactions., Int J Epidemiol., 48, 702-712, 10.1093/ije/dyy204 · DOI · Paper page
- M Munafò, 2018, Collider scope: when selection bias can substantially influence observed associations., Int J Epidemiol., 47, 226-235, 10.1093/ije/dyx206 · DOI · Paper page
- A Gkatzionis, 2019, Contextualizing selection bias in Mendelian randomization: how bad is it likely to be?, Int J Epidemiol., 48, 691-701, 10.1093/ije/dyy202 · DOI · Paper page
- J White, 2016, Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis., Lancet Diabetes Endocrinol., 4, 327-336, 10.1016/S2213-8587(15)00386-1 · DOI · Paper page
- J Bowden, 2018, Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression., Int J Epidemiol., 47, 1264-1278, 10.1093/ije/dyy101 · DOI · Paper page
- P Haycock, 2016, Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies., Am J Clin Nutr., 103, 965-978, 10.3945/ajcn.115.118216 · DOI · Paper page
- M Munafò, 2018, Robust research needs many lines of evidence., Nature., 553, 399-401, 10.1038/d41586-018-01023-3 · DOI · Paper page
- M Greco, 2015, Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome., Stat Med., 34, 2926-2940, 10.1002/sim.6522 · DOI · Paper page
- M Holmes, 2017, Mendelian randomization in cardiometabolic disease: challenges in evaluating causality., Nat Rev Cardiol., 14, 577-590, 10.1038/nrcardio.2017.78 · DOI · Paper page
Cited by
Sanderson, E., Glymour, M. M., Holmes, M. V., Kang, H., Morrison, J., Munafò, M. R., Palmer, T., Schooling, C. M., Wallace, C., Zhao, Q., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00092-5 · Cited by 2,229
Self-citationSkrivankova, V. W., Richmond, R. C., Woolf, B. A. R., Davies, N. M., Swanson, S. A., VanderWeele, T. J., Timpson, N. J., Higgins, J. P. T., Dimou, N., Langenberg, C., et al. (2021) · BMJ · doi:10.1136/bmj.n2233 · Cited by 1,648
Self-citationRichardson, T. G., Sanderson, E., Palmer, T. M., Ala-Korpela, M., Ference, B. A., Davey Smith, G., & Holmes, M. V. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003062 · Cited by 843
Self-citationMendelian Randomization: Concepts and Scope
Richmond, R. C., & Davey Smith, G. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a040501 · Cited by 841
Mountjoy, E., Schmidt, E. M., Carmona, M., Schwartzentruber, J., Peat, G., Miranda, A., Fumis, L., Hayhurst, J., Buniello, A., Karim, M. A., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00945-5 · Cited by 581
Zuber, V., Grinberg, N. F., Gill, D., Manipur, I., Slob, E. A. W., Patel, A., Wallace, C., & Burgess, S. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.04.001 · Cited by 532
Self-citationDavey Smith, G., Holmes, M. V., Davies, N. M., & Ebrahim, S. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00622-7 · Cited by 287
Self-citationPotential drug targets for multiple sclerosis identified through Mendelian randomization analysis
Lin, J., Zhou, J., & Xu, Y. (2023) · Brain · doi:10.1093/brain/awad070 · Cited by 271
Holmes, M. V., Richardson, T. G., Ference, B. A., Davies, N. M., & Davey Smith, G. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00493-1 · Cited by 184
Self-citationBjörnson, E., Adiels, M., Taskinen, M.-R., Burgess, S., Rawshani, A., Borén, J., & Packard, C. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad337 · Cited by 183
Self-citationAre Mendelian randomization investigations immune from bias due to reverse causation?
Burgess, S., Swanson, S. A., & Labrecque, J. A. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00726-8 · Cited by 106
Self-citationYang, Q., Sanderson, E., Tilling, K., Borges, M. C., & Lawlor, D. A. (2019) · doi:10.1101/19009605 · Cited by 85
Junqueira, C., Crespo, Â., Ranjbar, S., Ingber, J., Parry, B., Ravid, S., Lacerda, L. B. D., Lewandrowski, M., Clark, S., Ho, F., et al. (2021) · doi:10.1101/2021.03.06.21252796 · Cited by 70
Huang, Q. Q., Sallah, N., Dunca, D., Trivedi, B., Hunt, K. A., Hodgson, S., Lambert, S. A., Arciero, E., Wright, J., Griffiths, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32095-5 · Cited by 66
Tylee, D. S., Lee, Y. K., Wendt, F. R., Pathak, G. A., Levey, D. F., De Angelis, F., Gelernter, J., & Polimanti, R. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.0914 · Cited by 65
Huang, Y., Liu, Y., Ma, Y., Tu, T., Liu, N., Bai, F., Xiao, Y., Liu, C., Hu, Z., Lin, Q., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.840866 · Cited by 54
Yang, C., Fagan, A. M., Perrin, R. J., Rhinn, H., Harari, O., & Cruchaga, C. (2022) · Genome Medicine · doi:10.1186/s13073-022-01140-9 · Cited by 53
Iron status and the risk of sepsis and severe COVID-19: a two-sample Mendelian randomization study
Mohus, R. M., Flatby, H., Liyanarachi, K. V., DeWan, A. T., Solligård, E., Damås, J. K., Åsvold, B. O., Gustad, L. T., & Rogne, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-20679-6 · Cited by 28
Lemmelä, S., Wigmore, E. M., Benner, C., Havulinna, A. S., Ong, R. M., Kempf, T., Wollert, K. C., Blankenberg, S., Zeller, T., Peters, J. E., et al. (2022) · eLife · doi:10.7554/elife.76272 · Cited by 28
Gao, Z., Li, B., Guo, X., Bai, W., & Kou, C. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04760-6 · Cited by 22
Ahmed, A., Sattar, N., & Yaghootkar, H. (2022) · Diabetic Medicine · doi:10.1111/dme.14982 · Cited by 10
He, Y., Chen, C.-L., He, J., & Liu, S.-D. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i44.5872 · Cited by 10
Debette, S., Caro, I., Western, D., Namba, S., Sun, N., Kawaguchi, S., He, Y., Fujita, M., Roshchupkin, G., D'Aoust, T., et al. (2024) · doi:10.21203/rs.3.rs-4535534/v1 · Cited by 5
Wang, Z., Wang, Z., Ji, X., Zhao, L., Zheng, K., Yu, W., Zhang, H., Chang, H., & Liu, F. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08301-z
Metadata
- Authors
- Burgess, S., Davey Smith, G., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Holmes, M. V., Minelli, C., Relton, C. L., & Theodoratou, E.
- Venue
- Wellcome Open Research
- Publisher
- F1000 Research Ltd
- Published
- 2019-11-26
- Volume
- 4
- Pages
- 186
- ISSN
- 2398-502X (ISSN-L)
- OpenAlex
- W4253754191
- Cited by
- 1,834
- References
- 41
- FWCI
- 41.99
- Type
- journal article
- Language
- en
- Update notices
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- Economic and Social Research Council (ES/N000757/1)
- Cancer Research UK (C31250/A22804)
- Wellcome Trust (204623)
- Medical Research Council (MC_UU_00011/5, MC_UU_12013/9, MC_UU_00011/1, MC_UU_12013/1)
- British Heart Foundation (FS/18/23/33512)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.